Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 8608497, 8 pages
https://doi.org/10.1155/2018/8608497
Research Article

Effect of Chlorogenic Acid Intake on Cognitive Function in the Elderly: A Pilot Study

1Department of Health and Nutrition, Yamagata Prefectural Yonezawa University of Nutrition Sciences, Yonezawa 992-0025, Japan
2Health Care Food Research Laboratories, Kao Corporation, Tokyo 131-8501, Japan
3R&D, Development Research, Health Care/Household/Chemicals, Kao Corporation, Tochigi 321-3497, Japan

Correspondence should be addressed to Morimasa Kato; pj.ca.enoy@otak-m

Received 31 July 2017; Revised 8 December 2017; Accepted 24 January 2018; Published 7 March 2018

Academic Editor: Cory S. Harris

Copyright © 2018 Morimasa Kato et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Prince, A. Wimo, M. Guerchet, G. C. Ali, Y. T. Wu, and M. Prina, “Proceedings of the World Alzheimer Report, 2015., The Global Impact of Dementia: an Analysis of Prevalence, Incidence, Cost and Trends,” London, UK, 2015.
  2. H.-X. Wang, Y. Jin, H. C. Hendrie et al., “Late life leisure activities and risk of cognitive decline,” The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, vol. 68, no. 2, pp. 205–213, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. E. E. Devore, F. Grodstein, F. J. A. Van Rooij et al., “Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk,” American Journal of Clinical Nutrition, vol. 90, no. 1, pp. 170–176, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. E. Devore, F. Grodstein, F. J. A. van Rooij et al., “Dietary antioxidants and long-term risk of dementia,” JAMA Neurology, vol. 67, no. 7, pp. 819–825, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Gu and N. Scarmeas, “Dietary patterns in Alzheimer's disease and cognitive aging,” Current Alzheimer Research, vol. 8, no. 5, pp. 510–519, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Calon, G. P. Lim, F. Yang et al., “Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model,” Neuron, vol. 43, no. 5, pp. 633–645, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. S. Tan, W. S. Harris, A. S. Beiser et al., “Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging,” Neurology, vol. 78, no. 9, pp. 658–664, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Kuriyama, A. Hozaka, K. Ohmori et al., “Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project,” American Journal of Clinical Nutrition, vol. 83, pp. 355–361, 2006. View at Google Scholar
  9. B. M. van Gelder, B. Buijsse, M. Tijhuis et al., “Coffee consumption is inversely associated with cognitive decline in elderly European men: The FINE Study,” European Journal of Clinical Nutrition, vol. 61, no. 2, pp. 226–232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. E. D. Martín and W. Buño, “Caffeine-mediated presynaptic long-term potentiation in hippocampal CA1 pyramidal neurons,” Journal of Neurophysiology, vol. 89, no. 6, pp. 3029–3038, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. M. N. Clifford, “Chlorogenic acids and other cinnamates —nature, occurrence and dietary burden,” Journal of the Science of Food and Agriculture, vol. 79, no. 3, pp. 362–372, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. S.-H. Kwon, H.-K. Lee, J.-A. Kim et al., “Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice,” European Journal of Pharmacology, vol. 649, no. 1–3, pp. 210–217, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Ito, X.-L. Sun, M. Watanabe, M. Okamoto, and T. Hatano, “Chlorogenic acid and its metabolite m-coumaric acid evoke neurite outgrowth in hippocampal neuronal cells,” Bioscience, Biotechnology, and Biochemistry, vol. 72, no. 3, pp. 885–888, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Farah, M. Monteiro, C. M. Donangelo, and S. Lafay, “Chlorogenic acids from green coffee extract are highly bioavailable in humans,” Journal of Nutrition, vol. 138, no. 12, pp. 2309–2315, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. H. E. Lee, D. H. Kim, S. J. Park et al., “Neuroprotective effect of sinapic acid in a mouse model of amyloid β1-42 protein-induced Alzheimer's disease,” Pharmacology Biochemistry & Behavior, vol. 103, no. 2, pp. 260–266, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Ochiai, Y. Sugiura, Y. Shioya, K. Otsuka, Y. Katsuragi, and T. Hashiguchi, “Coffee polyphenols improve peripheral endothelial function after glucose loading in healthy male adults,” Nutrition Research, vol. 34, no. 2, pp. 155–159, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Ota, S. Soga, T. Murase, A. Shimotoyodome, and T. Hase, “Consumption of coffee polyphenols increases fat utilization in humans,” Journal of Health Science, vol. 56, no. 6, pp. 745–751, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Satake, K. Senda, Y.-J. Hong et al., “Validity of the Kihon Checklist for assessing frailty status,” Geriatrics & Gerontology International, vol. 16, no. 6, pp. 709–715, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Roehrs and T. Roth, “Caffeine: sleep and daytime sleepiness,” Sleep Medicine Reviews, vol. 12, no. 2, pp. 153–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. S. Lewis, K. M. Dingwall, N. Berkhout, S. Sayers, P. Maruff, and S. Cairney, “Assessment of cognition in an adolescent Indigenous population,” Australian Psychologist, vol. 45, no. 2, pp. 123–131, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. C. T. Gualtieri and L. G. Johnson, “Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs,” Archives of Clinical Neuropsychology, vol. 21, no. 7, pp. 623–643, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Maruff, Y. Y. Lim, D. Darby et al., “Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer’s disease,” BMC Psychology, vol. 1, no. 1, 2013. View at Publisher · View at Google Scholar
  23. D. P. McCabe, H. L. Roediger, M. A. McDaniel, D. A. Balota, and D. Z. Hambrick, “The relationship between working memory capacity and executive functioning: Evidence for a common executive attention construct,” Neuropsychology, vol. 24, no. 2, pp. 222–243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Nakatani, S.-I. Kayano, H. Kikuzaki, K. Sumino, K. Katagiri, and T. Mitani, “Identification, quantitative determination, and antioxidative activities of chlorogenic acid isomers in prune (Prunus domestica L.),” Journal of Agricultural and Food Chemistry, vol. 48, no. 11, pp. 5512–5516, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Cheignon, M. Tomas, D. Bonnefont-Rousselot, P. Faller, C. Hureau, and F. Collin, “Oxidative stress and the amyloid beta peptide in Alzheimer’s disease,” Redox Biology, vol. 14, pp. 450–464, 2017. View at Publisher · View at Google Scholar
  26. R. Mayeux, L. S. Honig, M.-X. Tang et al., “Plasma Aβ40 and Aβ42 and Alzheimer’s disease: relation to age, mortality, and risk,” Neurology, vol. 61, no. 9, pp. 1185–1190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Schupf, M. X. Tang, H. Fukuyama et al., “Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease,” Proceedings of the National Acadamy of Sciences of the United States of America, vol. 105, no. 37, pp. 14052–14057, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Mayeux, M.-X. Tang, D. M. Jacobs et al., “Plasma amyloid β-peptide 1-42 and incipient Alzheimer's disease,” Annals of Neurology, vol. 46, no. 3, pp. 412–416, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Gu, N. Schupf, S. A. Cosentino, J. A. Luchsinger, and N. Scarmeas, “Nutrient intake and plasma β-amyloid,” Neurology, vol. 78, no. 23, pp. 1832–1840, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Yokoyama, K. Okazaki, D. Imai et al., “The effect of cognitive-motor dual-task training on cognitive function and plasma amyloid β peptide 42/40 ratio in healthy elderly persons: A randomized controlled trial,” BMC Geriatrics, vol. 15, no. 1, article no. 60, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Ochiai, H. Jokura, A. Suzuki et al., “Green coffee bean extract improves human vasoreactivity,” Hypertension Research, vol. 27, no. 10, pp. 731–737, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Watanabe, Y. Arai, Y. Mitsui et al., “The blood pressure-lowering effect and safety of chlorogenic acid from green coffee bean extract in essential hypertension,” Clinical and Experimental Hypertension, vol. 28, no. 5, pp. 439–449, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M. F. Elias, A. L. Goodell, and G. A. Dore, “Hypertension and cognitive functioning: A perspective in historical context,” Hypertension, vol. 60, no. 2, pp. 260–268, 2012. View at Publisher · View at Google Scholar · View at Scopus